Back to News

OIS Retina Innovation Summit @ASRS, Austin, TX (USA)

OIS Retina Innovation Summit preceding ASRS will be held on Thursday, October 7th, at the Grand Hyatt San Antonio River Walk in San Antonio, TX. The summit is organized by the OIS community GenSight Biologics is a Bronze sponsor at the OIS event. Dr Magali Taiel, Chief Medical Officer, will present GenSight and its latest news about our most advanced product called LUMEVOQ® (GS010; lenadogene nolparvovec), a gene therapy targeting Leber Hereditary Optic Neuropathy (LHON), a rare mitochondrial disease leading to blindness in young adults. The LUMEVOQ®
  • Day: Thursday October 7, 2021
  • Time: 09 am CDT
 
Back to News

A New Chapter

Founded in 2012 to realize the potential of gene therapy, GenSight Biologics has grown into a clinical-stage company advancing multiple programs. In 2024, under a new management team, the company entered a new phase and is now accelerating its clinical and regulatory activities.

Explore investors’ hub

GenSight Biologics S.A.
74 rue du Faubourg Saint-Antoine
75012 Paris
France